References
- Bhutta ZA , ChopraM , AxelsonHet al. Countdown to 2015 decade report (2000–2010): taking stock of maternal, newborn, and child survival. Lancet 375 ( 9730 ), 2032 – 2044 ( 2010 ).
- Meis PJ , GoldenbergRL , MercerBMet al. The preterm prediction study: risk factors for indicated preterm births. Maternal-Fetal Medicine Units Network of the National Institute of Child Health and Human Development. Am. J. Obstet. Gynecol. 178 ( 3 ), 562 – 567 ( 1998 ).
- Shennan AH , RedmanC , CooperC , MilneF. Are most maternal deaths from pre-eclampsia avoidable?Lancet379 ( 9827 ), 1686 – 1687 ( 2012 ).
- Cnossen JS , ter RietG , MolBWet al. Are tests for predicting pre-eclampsia good enough to make screening viable? A review of reviews and critical appraisal. Acta Obstet. Gynecol. Scand. 88 ( 7 ), 758 – 765 ( 2009 ).
- Thangaratinam S , IsmailKM , SharpS , CoomarasamyA , KhanKS. Accuracy of serum uric acid in predicting complications of pre-eclampsia: a systematic review.BJOG113 ( 4 ), 369 – 378 ( 2006 ).
- Thangaratinam S , CoomarasamyA , O’MahonyFet al. Estimation of proteinuria as a predictor of complications of pre-eclampsia: a systematic review. BMC Med. 7 , 10 ( 2009 ).
- Thangaratinam S , KoopmansCM , IyengarSet al. Accuracy of liver function tests for predicting adverse maternal and fetal outcomes in women with preeclampsia: a systematic review. Acta Obstet. Gynecol. Scand. 90 ( 6 ), 574 – 585 ( 2011 ).
- Burton GJ , WoodsAW , JauniauxE , KingdomJC. Rheological and physiological consequences of conversion of the maternal spiral arteries for uteroplacental blood flow during human pregnancy.Placenta30 ( 6 ), 473 – 482 ( 2009 ).
- Levine RJ , MaynardSE , QianCet al. Circulating angiogenic factors and the risk of preeclampsia. N. Engl. J. Med. 350 ( 7 ), 672 – 683 ( 2004 ).
- Rana S , PoweCE , SalahuddinSet al. Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia. Circulation 125 ( 7 ), 911 – 919 ( 2012 ).
- Chappell LC , DuckworthS , SeedPTet al. Diagnostic accuracy of placental growth factor in women with suspected preeclampsia: a prospective multicenter study. Circulation 128 ( 19 ), 2121 – 2131 ( 2013 ).
- Hui D , OkunN , MurphyK , KingdomJ , UlerykE , ShahPS. Combinations of maternal serum markers to predict preeclampsia, small for gestational age, and stillbirth: a systematic review.J. Obstet. Gynaecol. Can.34 ( 2 ), 142 – 153 ( 2012 ).
- Cetin I , HuppertzB , BurtonGet al. Pregenesys pre-eclampsia markers consensus meeting: What do we require from markers, risk assessment and model systems to tailor preventive strategies? Placenta 32 ( Suppl. ), S4 – S16 ( 2011 ).
- Sibiude J , GuibourdencheJ , DionneMDet al. Placental growth factor for the prediction of adverse outcomes in patients with suspected preeclampsia or intrauterine growth restriction. PLoS ONE 7 ( 11 ), e50208 ( 2012 ).
- Chaiworapongsa T , RomeroR , KorzeniewskiSJet al. Maternal plasma concentrations of angiogenic/antiangiogenic factors in the third trimester of pregnancy to identify the patient at risk for stillbirth at or near term and severe late preeclampsia. Am. J. Obstet. Gynecol. 208 ( 4 ), 287 e1 – e15 ( 2013 ).
- Hadker N , GargS , CostanzoCet al. Financial impact of a novel pre-eclampsia diagnostic test versus standard practice: a decision-analytic modeling analysis from a UK healthcare payer perspective. J. Med. Econ. 13 ( 4 ), 728 – 737 ( 2010 ).
- Ferrante di Ruffano L , HydeCJ , McCafferyKJ , BossuytPM , DeeksJJ. Assessing the value of diagnostic tests: a framework for designing and evaluating trials.BMJ344 , e686 ( 2012 ).
- Bramham K , SeedPT , Nelson-PiercyCet al. Diagnostic accuracy of placental growth factor in women with chronic kidney disease and suspected preeclampsia: a prospective cohort study. J. Am. Soc. Nephrol. 24 , 142A ( 2013 ).
- Staff AC , BentonSJ , von DadelszenPet al. Redefining preeclampsia using placenta-derived biomarkers. Hypertension 61 ( 5 ), 932 – 942 ( 2013 ).